These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 19112682

  • 21. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Dec 02; 67(235):72555-9. PubMed ID: 12474879
    [Abstract] [Full Text] [Related]

  • 22. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug 27; 63(166):45716-7. PubMed ID: 10182694
    [Abstract] [Full Text] [Related]

  • 23. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 04; 68(107):33362-81. PubMed ID: 12785379
    [Abstract] [Full Text] [Related]

  • 24. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Sep 22; 63(183):50660-704. PubMed ID: 10185803
    [Abstract] [Full Text] [Related]

  • 25. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 04; 72(232):68064-70. PubMed ID: 18064770
    [Abstract] [Full Text] [Related]

  • 26. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
    Fed Regist; 2000 May 03; 65(86):25639-41. PubMed ID: 11010689
    [Abstract] [Full Text] [Related]

  • 27. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Aug 31; 63(168):46171-4. PubMed ID: 10182698
    [Abstract] [Full Text] [Related]

  • 28. Food labeling: health claims; calcium consumption by adolescents and adults, bone density and the risk of fractures--FDA. Interim final rule.
    Fed Regist; 1998 Jun 22; 63(119):34101-4. PubMed ID: 10180287
    [Abstract] [Full Text] [Related]

  • 29. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Aug 22; 73(164):49603-10. PubMed ID: 18958946
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 09; 68(110):34273-93. PubMed ID: 12795305
    [Abstract] [Full Text] [Related]

  • 32. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 31; 68(250):75414-8. PubMed ID: 14986677
    [Abstract] [Full Text] [Related]

  • 33. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Nov 27; 66(228):59138-61. PubMed ID: 11776289
    [Abstract] [Full Text] [Related]

  • 34. Food labeling: health claims; zinc and the body's ability to fight infection and heal wounds in adults--FDA. Interim final rule.
    Fed Regist; 1998 Jun 22; 63(119):34112-5. PubMed ID: 10180291
    [Abstract] [Full Text] [Related]

  • 35. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec 03; 64(232):67720-63. PubMed ID: 11010665
    [Abstract] [Full Text] [Related]

  • 36. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Dec 14; 63(239):68710-2. PubMed ID: 10187560
    [Abstract] [Full Text] [Related]

  • 37. Food labeling: health claims; vitamin K and promotion of proper blood clotting and improvements in bone health in adults--FDA. Interim final rule.
    Fed Regist; 1998 Jun 22; 63(119):34115-7. PubMed ID: 10180292
    [Abstract] [Full Text] [Related]

  • 38. Labeling requirements for systemic antibacterial drug products intended for human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Feb 06; 68(25):6062-81. PubMed ID: 12577966
    [Abstract] [Full Text] [Related]

  • 39. Conforming regulations regarding removal of section 507 of the Federal Food, Drug, and Cosmetic Act; confirmation of effective date. Food and Drug Administration, HHS. Direct final rule; confirmation of effective date.
    Fed Regist; 1999 May 17; 64(94):26657. PubMed ID: 10558515
    [Abstract] [Full Text] [Related]

  • 40. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 11; 68(238):69009-20. PubMed ID: 14672084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.